Lunai Bioworks (LNAI) Equity Ratio (2011 - 2026)

Lunai Bioworks' Equity Ratio history runs 16 years deep, the most recent figure standing at 0.97 for Q1 2026.

• In Q1 2026, Equity Ratio fell 229.05% year-over-year to 0.97; the TTM figure through Mar 2026 stood at 0.97 (down 229.05% YoY), while the FY2025 annual figure was 2.59, down 420.62% from the prior year.
• Equity Ratio was 0.97 for Q1 2026 at Lunai Bioworks, up from 2.03 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.9 in Q1 2022 to a low of 2.59 in Q2 2025.
• Historically, Equity Ratio has averaged 0.18 across 5 years, with a median of 0.8 in 2023.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio rose 1.43% in 2024, then plunged 420.62% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.83 in 2022, then dropped by 9.84% to 0.75 in 2023, then slipped by 1.92% to 0.74 in 2024, then slumped by 375.76% to 2.03 in 2025, then soared by 52.33% to 0.97 in 2026.
• The last three Equity Ratio figures came in at 0.97 (Q1 2026), 2.03 (Q4 2025), and 1.87 (Q3 2025), per Business Quant data.